454 Sells Four Sequencers in Q3; Expect Positive Cash Flow for 2005

genomeweb
360dx

454 Sells Four Sequencers in Q3; Expect Positive Cash Flow for 2005

Oct 27, 2005

NEW YORK, Oct. 27 (GenomeWeb News) - 454 Life Sciences sold and installed four Genome Sequencer 20 Systems in the third quarter, 454's parent company CuraGen said today, bringing the total of confirmed installations to nine.

To read the full story....

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

UgenTec, Serosep Partner on Molecular Test Automation, Interpretation
Mobidiag Gets CE Mark for Two Tests
BioMérieux Q1 Revenues Up 3 Percent
Danaher Q1 Revenues Grow 12 Percent
FDA Expands Approval of Roche Cobas Test as CDx for EGFR Deletions, Mutations
Curetis Gets CE Mark for UTI Test

The Scan

Drive Away the Flies

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

This Week in Nature

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Alteration Here and There to Win

Futurism writes that gene doping could be the next generation of cheating in sports.

Of Mice and Microbes

Mice in New York harbor both antibiotic-resistant bacteria and novel viruses, according to a new analysis of their fecal microbiomes.

Main menu